1.90
price down icon5.94%   -0.12
after-market Dopo l'orario di chiusura: 1.82 -0.08 -4.21%
loading

Immuron Limited Adr Borsa (IMRN) Ultime notizie

pulisher
Oct 31, 2025

[6-K] Immuron Ltd Current Report (Foreign Issuer) - Stock Titan

Oct 31, 2025
pulisher
Oct 31, 2025

Immuron Announces Clinical Trial Update - GlobeNewswire Inc.

Oct 31, 2025
pulisher
Oct 31, 2025

Immuron Announces Clinical Trial Update - Sahm

Oct 31, 2025
pulisher
Oct 20, 2025

Immuron CEO to Present at AusBiotech Invest 2025 Conference - TipRanks

Oct 20, 2025
pulisher
Oct 17, 2025

IMRN furnishes 6-K with ASX updates and Exhibit 99.1 - Stock Titan

Oct 17, 2025
pulisher
Oct 13, 2025

Immuron Ltd. (ADR) (US45254U1016.SG) Stock Price, News, Quote & History - Yahoo

Oct 13, 2025
pulisher
Oct 12, 2025

Immuron Limited Announces 2025 Annual General Meeting - MSN

Oct 12, 2025
pulisher
Oct 10, 2025

[6-K] Immuron Ltd Current Report (Foreign Issuer) | IMRN SEC FilingForm 6-K - Stock Titan

Oct 10, 2025
pulisher
Oct 09, 2025

Immuron Submits IMM-529 IND to FDA - markets.businessinsider.com

Oct 09, 2025
pulisher
Oct 08, 2025

Immuron (IMRN) Seeks FDA Green Light for Novel C. diff Treatment - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Immuron Limited Submits IND Application to FDA for IMM-529 to Combat Clostridioides difficile Infection - Quiver Quantitative

Oct 08, 2025
pulisher
Oct 02, 2025

$400M Market Potential: Immuron's C. Difficile Drug IMM-529 Heads to FDA as Company Advances 3 Key Programs - Stock Titan

Oct 02, 2025
pulisher
Sep 30, 2025

Immuron Limited Secures Auditor Consent for Financial Filings - MSN

Sep 30, 2025
pulisher
Sep 28, 2025

What analysts say about Immuron Limited ANW stockBear Market Strategies & Low Risk Capital Gains - earlytimes.in

Sep 28, 2025
pulisher
Sep 13, 2025

Is Immuron Limited Depositary Receipt forming a reversal patternJuly 2025 Earnings & Low Risk Entry Point Guides - newser.com

Sep 13, 2025
pulisher
Sep 07, 2025

Is it too late to sell Immuron Limited Depositary ReceiptMarket Activity Report & Fast Moving Trade Plans - Newser

Sep 07, 2025
pulisher
Aug 29, 2025

Does Immuron Limited Depositary Receipt fit your quant trading modelJuly 2025 Price Swings & High Win Rate Trade Tips - Newser

Aug 29, 2025
pulisher
Aug 28, 2025

Statistical indicators supporting Immuron Limited Depositary Receipt’s strengthPortfolio Risk Summary & Real-Time Sentiment Analysis - Newser

Aug 28, 2025
pulisher
Aug 27, 2025

What institutional flow reveals about Immuron Limited Depositary ReceiptEarnings Growth Summary & Entry Point Strategy Guides - Newser

Aug 27, 2025
pulisher
Aug 16, 2025

Immuron Limited Depositary Receipt stock trend forecastWeekly Investment Summary & AI Optimized Trading Strategy Guides - Newser

Aug 16, 2025
pulisher
Aug 01, 2025

Visualizing Immuron Limited Depositary Receipt stock with heatmapsAI Trading Forecast Based on Big Data - Newser

Aug 01, 2025
pulisher
Jul 22, 2025

BNY Mellon Increases Stake in Immuron Limited - TipRanks

Jul 22, 2025
pulisher
Jul 21, 2025

Immuron Limited Announces Cessation of Securities - TipRanks

Jul 21, 2025
pulisher
Jul 19, 2025

What drives Immuron Limited Depositary Receipt stock priceHigh-yield capital appreciation - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 17, 2025

Immuron - GlobeNewswire Inc.

Jul 17, 2025
pulisher
Jul 17, 2025

Immuron Crushes Sales Forecast: North America Soars 76%, Global Revenue Breaks Records at $7.3M - Stock Titan

Jul 17, 2025
pulisher
Jun 04, 2025

immuron ltd files for quotation of securities on ASX By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

immuron ltd files for quotation of securities on ASX - Investing.com

Jun 04, 2025
pulisher
May 04, 2025

IMRNImmuron Ltd Latest Stock News & Market Updates - Stock Titan

May 04, 2025
pulisher
Mar 05, 2025

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) - BioSpace

Mar 05, 2025
pulisher
Jan 30, 2025

Immuron: Targeted oral antibodies to treat infectious diseases - Innovation News Network

Jan 30, 2025
pulisher
Jan 17, 2025

Immuron Travelan® continued strong sales growth - FinancialContent

Jan 17, 2025
pulisher
Sep 06, 2024

Immuron: US FDA provides favourable feedback ahead of investigational new drug application for IMM-529 - Proactive financial news

Sep 06, 2024
pulisher
Sep 05, 2024

Immuron Plans Phase 2 Trial for IMM-529 following FDA review - GlobeNewswire

Sep 05, 2024
pulisher
Jul 02, 2024

Immuron requests pre-IND meeting for IMM-529 with FDA filing - FinancialContent

Jul 02, 2024
pulisher
Mar 26, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 26, 2024
pulisher
Mar 07, 2024

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.34% - Investing.com

Mar 07, 2024
pulisher
Jul 23, 2020

Immuron Limited Announces Closing of $20.0 Million Registered Direct Offering - Stock Titan

Jul 23, 2020
pulisher
Mar 18, 2020

The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates - Yahoo Finance

Mar 18, 2020
pulisher
Jun 07, 2018

IMC Reports Rising Revenues & Eyes Colitis Market - Next Investors

Jun 07, 2018
pulisher
Mar 07, 2018

Immuron Limited Issues Correction to Misleading Halt Announcement Headline - GlobeNewswire

Mar 07, 2018
pulisher
Jul 19, 2017

IMC Stock Price and Chart — ASX:IMC - TradingView

Jul 19, 2017
pulisher
Jul 10, 2017

Immuron Limited (IMRN) stock price, news, quote and history - Yahoo! Finance UK

Jul 10, 2017
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Capitalizzazione:     |  Volume (24 ore):